Thymopentin

From Wikipedia, the free encyclopedia

Thymopentin

Systematic (IUPAC) name
L-arginyl-L-lysyl-L-α-aspartyl-L-valyl-L-tyrosine
Clinical data
Legal status	?
Identifiers

ATC code	L03AX09
PubChem	CID 451417
ChemSpider	397640^Y
UNII	O3Y80ZF13F^Y
KEGG	D06117^Y
ChEMBL	CHEMBL156025^Y
NIAID ChemDB	000127
Synonyms	(3S)-3-[[(2S)-6-amino-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-4-[[(2S)-1-[[(2S)-1-hydroxy-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid
Chemical data
Formula	C₃₀H₄₉N₉O₉
Mol. mass	679.76496 g/mol
SMILES O=C(N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccc(O)cc1)C(C)C)CC(=O)O)CCCCN)[C@@H](N)CCC/N=C(\N)N
InChI InChI=1S/C30H49N9O9/c1-16(2)24(28(46)38-22(29(47)48)14-17-8-10-18(40)11-9-17)39-27(45)21(15-23(41)42)37-26(44)20(7-3-4-12-31)36-25(43)19(32)6-5-13-35-30(33)34/h8-11,16,19-22,24,40H,3-7,12-15,31-32H2,1-2H3,(H,36,43)(H,37,44)(H,38,46)(H,39,45)(H,41,42)(H,47,48)(H4,33,34,35)/t19-,20-,21-,22-,24-/m0/s1^Y Key:PSWFFKRAVBDQEG-YGQNSOCVSA-N^Y
Y (what is this?) (verify)

Thymopentin is an immunostimulant. As such, it has been used in several clinical studies in the early years of the AIDS pandemic (from 1983 to 1985). Thymopentin helped to improve immunological condition in several patients for a brief time under specific treatments.^[1]^[2]^[3]

It interacts with T cells.^[4]

It is a thymic polypeptide.^[5]

References

↑ Mascart-Lemone F, Huygen K, Clumeck N, Brenez D, Bolla K, Duchateau J (1983). "Stimulation of cellular function by thymopentin (TP-5) in three AIDS patients". Lancet. 322 (8352): 735–736. doi:10.1016/S0140-6736(83)92271-7. PMID 6193382.
↑ Clumeck N, Van de Perre P, Mascart-Lemone F, Cran S, Bolla K, Duchateau J (1984). "Preliminary results on clinical and immunological effects of thymopentin in AIDS". Int J Clin Pharmacol Res 4: 459–463. PMID 6398315.
↑ Clumeck N, Cran S, Van de Perre P, Mascart-Lemone F, Duchateau J, Bolla K (1985). "Thymopentin treatment in AIDS and pre-AIDS patients". Surv Immunol Res 4 (1): supp1 58–62. PMID 3898293.
↑ Liu Z, Zheng X, Wang J, Wang E (2007). "Molecular analysis of thymopentin binding to HLA-DR molecules". In Egli, Martin. PLoS ONE 2 (12): e1348. doi:10.1371/journal.pone.0001348. PMC 2137936. PMID 18159232.
↑ Peng Y, Chen Z, Yu W, et al. (July 2008). "Effects of thymic polypeptides on the thymopoiesis of mouse embryonic stem cells". Cell biology international 32 (10): 1265–71. doi:10.1016/j.cellbi.2008.07.011. PMID 18692582.

Immunomodulators: Immunostimulants (L03)

Endogenous

Cytokines

Colony-stimulating factors	G-CSF Filgrastim / Pegfilgrastim Lenograstim GM-CSF Molgramostim Sargramostim SCF Ancestim

Interferons	alpha: Albinterferon Interferon alfa natural Interferon alfa 2a / Peginterferon alfa-2a Interferon alfa 2b / Peginterferon alfa-2b Interferon alfa n1 Interferon alfacon-1 Interferon alpha-n3 beta: Interferon beta natural Interferon beta 1a Interferon beta 1b Interferon gamma

Interleukins	Aldesleukin Oprelvekin

Other protein / peptide

Growth hormone
Immunocyanin
Pegademase
Prolactin
Tasonermin

Other

Exogenous

beta-glucan
- Lentinan
heterocyclic compound
- Plerixafor
hydroxyquinoline
- Roquinimex
Mifamurtide
oligopeptides
polyribonucleotide
- Polyinosinic:polycytidylic acid
thiazolidine
- Pidotimod
vaccines
- Bacillus Calmette–Guérin
- Melanoma vaccine
- Sipuleucel-T

M: LMC

cell/phys/auag/auab/comp, igrc

imdf/ipig/hyps/tumr

proc, drug (L3/4)

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.